Beijing Biostar Pharms Co Ltd
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Beijing Biostar Pharms Co Ltd is publicly traded on HKSE under the ticker 2563.HK.
Beijing Biostar Pharmaceuticals Co. Ltd. primarily focuses on developing innovative therapies for tumors. The company is dedicated to creating novel anti-cancer drugs, each secured by independent intellectual property rights. A prominent product in its portfolio is the Utidelone injection, a next-generation microtubule inhibitor produced through a unique microbial fermentation process. This enterprise was co-founded...
Can you invest in Beijing Biostar Pharms Co Ltd?
Yes. Beijing Biostar Pharms Co Ltd trades publicly on HKSE as 2563.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Beijing Biostar Pharms Co Ltd
Detailed equity research is provided by MarketSnap.